Edition:
India

Intra-Cellular Therapies Inc (ITCI.OQ)

ITCI.OQ on NASDAQ Stock Exchange Global Select Market

18.65USD
22 Jun 2018
Change (% chg)

$0.19 (+1.03%)
Prev Close
$18.46
Open
$18.62
Day's High
$18.94
Day's Low
$17.58
Volume
608,221
Avg. Vol
159,711
52-wk High
$25.74
52-wk Low
$10.25

Chart for

About

Intra-Cellular Therapies, Inc. (ITI) is a biopharmaceutical company. The Company is focused on the discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system... (more)

Overall

Beta: 0.75
Market Cap(Mil.): $875.65
Shares Outstanding(Mil.): 53.10
Dividend: --
Yield (%): --

Financials

BRIEF-Intra-Cellular Therapies Reports Q1 Loss Per Share $0.65

* INTRA-CELLULAR THERAPIES REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

03 May 2018

BRIEF-Intra-Cellular Therapies Announces Positive Pre-NDA Meeting With FDA For Schizophrenia Treatment

* INTRA-CELLULAR THERAPIES ANNOUNCES POSITIVE PRE-NDA MEETING WITH FDA FOR LUMATEPERONE FOR THE TREATMENT OF SCHIZOPHRENIA

13 Mar 2018

BRIEF-Intra-Cellular Therapies Reports Q4 Loss Per Share $0.56

* INTRA-CELLULAR THERAPIES REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

01 Mar 2018

Earnings vs. Estimates